3, 3′- DIINDOLYLMETHANE ENHANCES CHEMOSENSITIVITY OF MULTIPLE CHEMOTHERAPEUTIC AGENTS IN PANCREATIC CANCER

Por Banerjee, Sanjeev, Wang, Zhiwei, Kong, Dejuan, Sarkar, Fazlul H.
Publicado em 2009

Cellular signaling perturbation by natural products

Por Sarkar, Fazlul H., Li, Yiwei, Wang, Zhiwei, Kong, Dejuan
Publicado em 2009

Pancreatic cancer stem cells and EMT in drug resistance and metastasis

Por Sarkar, Fazlul H., Li, Yiwei, Wang, Zhiwei, Kong, Dejuan
Publicado em 2009

The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer

Por Sarkar, Fazlul H., Li, Yiwei, Wang, Zhiwei, Kong, Dejuan
Publicado em 2010

Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research

Por Li, Yiwei, Kong, Dejuan, Wang, Zhiwei, Sarkar, Fazlul H.
Publicado em 2010

Novel targets for prostate cancer chemoprevention

Por Sarkar, Fazlul H, Li, Yiwei, Wang, Zhiwei, Kong, Dejuan
Publicado em 2010

The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness

Por Wang, Zhiwei, Li, Yiwei, Kong, Dejuan, Sarkar, Fazlul H.
Publicado em 2010

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

Por Kong, Dejuan, Li, Yiwei, Wang, Zhiwei, Sarkar, Fazlul H.
Publicado em 2011

Implication of microRNAs in drug resistance for designing novel cancer therapy

Por Sarkar, Fazlul H, Li, Yiwei, Wang, Zhiwei, Kong, Dejuan, Ali, Shadan
Publicado em 2010

Induction of Cancer Cell Death by Isoflavone: The Role of Multiple Signaling Pathways

Por Li, Yiwei, Kong, Dejuan, Bao, Bin, Ahmad, Aamir, Sarkar, Fazlul H.
Publicado em 2011

Targeting Bone Remodeling by Isoflavone and 3,3′-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis

Por Li, Yiwei, Kong, Dejuan, Ahmad, Aamir, Bao, Bin, Sarkar, Fazlul H.
Publicado em 2012

Pancreatic cancer stem cells: Emerging target for designing novel therapy

Por Li, Yiwei, Kong, Dejuan, Ahmad, Aamir, Bao, Bin, Sarkar, Fazlul H.
Publicado em 2012

Antioxidant Function of Isoflavone and 3,3′-Diindolylmethane: Are They Important for Cancer Prevention and Therapy?

Por Li, Yiwei, Kong, Dejuan, Ahmad, Aamir, Bao, Bin, Sarkar, Fazlul H.
Publicado em 2013

Epigenetic regulation of miRNA-Cancer Stem Cells nexus by Nutraceuticals

Por Ahmad, Aamir, Li, Yiwei, Bao, Bin, Kong, Dejuan, Sarkar, Fazlul H.
Publicado em 2013

Recent Progress on Nutraceutical Research in Prostate Cancer

Por Li, Yiwei, Ahmad, Aamir, Kong, Dejuan, Bao, Bin, Sarkar, Fazlul H.
Publicado em 2014

Targeting MicroRNAs for Personalized Cancer Therapy

Por Li, Yiwei, Ahmad, Aamir, Kong, Dejuan, Bao, Bin, Sarkar, Fazlul H.
Publicado no Med Princ Pract (2013)

Forkhead Box M1 transcription factor: A novel target for cancer therapy

Por Wang, Zhiwei, Ahmad, Aamir, Li, Yiwei, Banerjee, Sanjeev, Kong, Dejuan, Sarkar, Fazlul H
Publicado em 2009

Crosstalk between miRNA and Notch signaling pathways in tumor development and progression

Por Wang, Zhiwei, Li, Yiwei, Kong, Dejuan, Ahmad, Aamir, Banerjee, Sanjeev, Sarkar, Fazlul H
Publicado em 2009

Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion

Por Li, Yiwei, Kong, Dejuan, Ahmad, Aamir, Bao, Bin, Dyson, Gregory, Sarkar, Fazlul H.
Publicado em 2012

Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells

Por Kong, Dejuan, Ahmad, Aamir, Bao, Bin, Li, Yiwei, Banerjee, Sanjeev, Sarkar, Fazlul H.
Publicado em 2012